Wells Fargo’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Wells Fargo’s Portfolio MIRO Stock Details MIRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-153	Closed	-$200	–	7766
2023 Q3	$200	Sell	153 -12	-7%	-$18	﹤0.01%	6589
2023 Q2	$289	Buy	165 +51	+45%	+$67	﹤0.01%	6594
2023 Q1	$192	Buy	114 +2	+2%	+$5	﹤0.01%	6786
2022 Q4	$335	Buy	112 +3	+3%	+$12	﹤0.01%	6489
2022 Q3	$0	Buy	109 +64	+142%	+$207	﹤0.01%	7672
2022 Q2	$0	Buy	45 +4	+10%	+$15	﹤0.01%	7778
2022 Q1	$0	Hold	41	–	–	﹤0.01%	8109
2021 Q4	$0	Buy	41 +12	+41%	+$85	﹤0.01%	8048
2021 Q3	$0	Buy	+29	New	+$273	﹤0.01%	7724

Wells Fargo's MIRO Position: Q4 2023 in Review

Wells Fargo sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 153 shares — an estimated $200 sold.

Wells Fargo first reported a position in MIRO in Q3 2021 and held it in 9 quarters. The position peaked at $335 in Q4 2022. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

Wells Fargo reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Wells Fargo sold 153 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $200.
Wells Fargo first reported a position in Miromatrix Medical Inc. Common Stock in Q3 2021 and held it in 9 quarters.
Wells Fargo's Miromatrix Medical Inc. Common Stock position peaked at $335 in Q4 2022.
0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.